Two different approaches were used to create MD2 deficits in colon cancer cells as follows: i) MD2 knockdown using siRNA target sequences (Figure 2B), and ii) neutralizing antibody to MD2. The gene discussed is LY96; the disease is malignant colon neoplasm.